Thanks GM, that would explain why they delayed on the first 510K re licensing, makes sense really, like you say, having the complete package i.e. Novopore and BTM for surgical wounds as a combined package and later for the burns as well maybe because it is basically the same as the surgical stuff, I reckon this last announcement has cleared the way for what you say,an announcement about this could be fairly soon in the new year.
Ann: PolyNovo's US FDA approval, page-42
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.03 |
Change
0.040(2.02%) |
Mkt cap ! $1.398B | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.05 | $1.99 | $1.560M | 772.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 60330 | $2.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.03 | 10057 | 21 |
View Market Depth
| Last trade - 12.49pm 07/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |